Replies to post #143261 on Biotech Values

[DewDiligence]

Although Elagolix hasn’t attracted as much attention from investors as Bardoxolone and ABT’s HCV pipeline, management considers it one of the most important drugs in ABT’s (soon to be Abbvie’s) late-stage pipeline.